Moderna Basic EPS 2017-2025 | MRNA

Moderna basic eps for the twelve months ending March 31, 2025 was $-8.73, a 44.04% decline year-over-year.

  • Moderna annual basic eps for 2024 was $-0.009B, a 24.74% decline from 2023.
  • Moderna annual basic eps for 2023 was $-0.012B, a 158% decline from 2022.
  • Moderna annual basic eps for 2022 was $0.021B, a 29.86% decline from 2021.

Moderna Basic EPS 2017-2025 | MRNA

  • Moderna annual basic eps for 2024 was $-0.009B, a 24.74% decline from 2023.
  • Moderna annual basic eps for 2023 was $-0.012B, a 158% decline from 2022.
  • Moderna annual basic eps for 2022 was $0.021B, a 29.86% decline from 2021.